Sicagen India Limited (BOM:533014)

Market Cap	2.78B
Revenue (ttm)	8.92B
Net Income (ttm)	171.10M
Shares Out	39.57M
EPS (ttm)	4.32
PE Ratio	16.26
Forward PE	n/a
Dividend	1.00 (1.42%)
Ex-Dividend Date	Sep 12, 2024

Volume	11,999
Average Volume	12,252
Open	70.24
Previous Close	70.24
Day's Range	69.00 - 71.69
52-Week Range	54.00 - 118.80
Beta	0.12
RSI	48.84
Earnings Date	Aug 8, 2025

About Verve Therapeutics

Sicagen India Limited, together with its subsidiaries, engages in the trade and distribution of building materials in India and internationally. It operates through Trading and Manufacturing segments. The company distributes building materials, such as MS/GI pipes, precision tubes, structural tubes, seamless tubes, ERW tubes, rectangular/square hollow sections, TMT steel bars, steel fittings, PVC pipes, UPVC pipes, roofing sheets, electrical cables, paints and construction chemicals, lighting solutions, electrical accessories, switchgears, etc....

• Industry: Machinery, Equipment, And Supplies
• Founded: 2004
• Employees: 281
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 533014

Financial Performance

In 2024, Sicagen India's revenue was 8.92 billion, an increase of 12.12% compared to the previous year's 7.95 billion. Earnings were 171.10 million, an increase of 63.11%.